Back to Results
First PageMeta Content
Pharmaceutical industry / Clinical research / Pharmacokinetics / Pharmaceuticals policy / Abbreviated New Drug Application / New Drug Application / Bioequivalence / Food and Drug Administration / Generic drug / Pharmaceutical sciences / Pharmacology / Pharmaceutics


FOLEY’ FOLEY & LARDNER LLP ATTORNEYS AT LAW WASHINGTON HARBOUR 3000 K STREET. N.W , SUITE 500
Add to Reading List

Document Date: 2005-09-13 17:22:29


Open Document

File Size: 523,29 KB

Share Result on Facebook

City

Rockville / WASHINGTON / WEST PALM BEACH / /

Company

sCT / B.S. Pharm / J.D. Foley & Lardner LLP / /

Currency

USD / /

/

Event

FDA Phase / /

Facility

LARDNER LLP ATTORNEYS AT LAW WASHINGTON HARBOUR / /

IndustryTerm

rDNA origin manufacturing / residual chemical contaminants / chemical synthesis / synthesized product / drug product / generic product / manufacturing / nasal spray products / uncoated rubber components / generic peptide/protein products / drug products / /

MedicalCondition

chronic administration / pure red cell aplasia / /

Organization

Food and Drug Administration / FDA / Food and Drugs / Center for Drug Evaluation and Research / Food and Drug Administration Department of Health and Human Services / /

Person

Nancy L. But / David L. Rosen / Steven K. Galson / Salmon Calcitonin / /

/

Position

Acting Director / Commissioner / WRITER / representative / /

Product

Miacalcin / Federal Food / Approved Drug / /

ProgrammingLanguage

C / /

ProvinceOrState

D C / Maryland / /

Technology

drug delivery / cell receptors / antibodies / recombinant DNA technology / /

URL

http /

SocialTag